Graetz Wealth »

Neurocrine Biosciences shares owned by Graetz Wealth

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Graetz Wealth from 13F filings

Historical chart of Graetz Wealth investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Graetz Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Graetz Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $246k 1.9k 131.77

More positions owned by Graetz Wealth

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Bd Index Fds Intermed Term (BIV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Series Trust State Street Spd (CWB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Series Trust State Street Spd (JNK)
Vanguard Specialized Funds Div App Etf (VIG)
Select Sector Spdr Tr State Street Ene (XLE)
Select Sector Spdr Tr State Street Fin (XLF)
Select Sector Spdr Tr State Street Tec (XLK)
Ishares Tr Pfd And Incm Sec (PFF)

View all positions for Graetz Wealth

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Thomas Stevens, CFA"
Northern Trust
Deerfield Management Company
Norges Bank Investment Management
Rtw Investments

View all funds holding Neurocrine Biosciences